Newsroom

About Hepion

Recent News

Contact Us

Recent Press Releases

View all Press Releases

Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma

March 3, 2026

Hepion Pharmaceuticals Successfully Completes Application to the OTCQB

June 25, 2025

Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer

June 16, 2025

Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

May 12, 2025

Media Contact

info@hepionpharma.com